Compare ACHV & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | ONL |
|---|---|---|
| Founded | N/A | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.0M | 141.5M |
| IPO Year | 2018 | 2021 |
| Metric | ACHV | ONL |
|---|---|---|
| Price | $4.98 | $2.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $14.67 | $3.00 |
| AVG Volume (30 Days) | ★ 1.5M | 316.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $147,647,000.00 |
| Revenue This Year | N/A | $4.10 |
| Revenue Next Year | N/A | $3.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.00 | $1.92 |
| 52 Week High | $6.16 | $3.04 |
| Indicator | ACHV | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 43.99 | 53.78 |
| Support Level | $4.09 | $2.81 |
| Resistance Level | $4.98 | $2.96 |
| Average True Range (ATR) | 0.42 | 0.09 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 8.59 | 44.44 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.